WHO Workshop on Lassa Vaccine evaluation 24 April 2018 - INSERM, 101 rue de Tolbiac, 75013 Paris
LIST OF PARTICIPANTS
Participants
Prof George O. Akpede
Department of Paediatrics, College of Medicine, Ambrose Alli University Nigeria
Dr Danny Asogun
Associate Professor, Department of Community Medicine, Ambrose Alli University / Irrua Specialist Teaching Hospital, Nigeria
Dr Augustin Augier
Secretary General, ALIMA - The Alliance for International Medical Action,
France
Prof Daniel G. Bausch
Director, UK Public Health Rapid Support Team,
UK
Dr Sina Bavari
Chief Scientific Officer/Scientific Director US. Army Medical Research Institute of Infectious Diseases,
USA
Prof Victor De Gruttola (TC)
Professor of Biostatistics, Department of Biostatistics, Harvard School of Public Health, USA
Prof W. John Edmunds
Professor, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, UK
Prof Susan S. Ellenberg
Professor of Biostatistics Department of Biostatistics and Epidemiology University of Pennsylvania Perelman School of Medicine, USA
Prof Thomas R. Fleming
Professor of Biostatistics, School of Public Health, University of Washington, USA
Dr Christiane Gerke
Head of Vaccine Programs, Development Department, Institut Pasteur, France
Dr Donald Grant (TC)
Chief Physician of the Viral Hemorrhagic Fever ward, Kenema Government Hospital, Ministry of Health and Sanitation of Sierra Leone, Sierra Leone
Prof Stephan Guenther
Head, Department of Virology, Bernhardt-Nocht-Institute for Tropical Medicine, Germany
Dr Norheim Gunnstein
Director, Vaccine Science, CEPI
Dr Chikwe Ihekweazu
Chief Executive Officer, Nigeria Centre for Disease Control,
Nigeria
Prof Albert I. Ko
Professor of Epidemiology and Medicine, Chair Department of Epidemiology of Microbial Diseases, Yale School of Public Health,
USA
Dr Philip R. Krause
Deputy Director, Center for Biologics Evaluation and Research, US Food and Drug Administration, USA
Dr Gianni Lo Iacono
Lecturer in Biostatistics/Epidemiology, University of Surrey,
UK
Prof Yves Lévy Chief Executive Officer
INSERM
Prof Ira M. Longini
Professor of Biostatistics, Department of Biostatistics, University of Florida, USA
Prof Denis Malvy
Head of the Tropical Medicine Unit, University Hospital of Bordeaux and INSERM,
France
Dr Martha C. Nason
Mathematical Statistician, Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, USA
Dr Edwin Nkansah
Head of Biological Products Units, Ghana Food and Drug Administration,
Ghana
Prof Sylvanus Okogbenin
Chief Medical Director, Irrua Specialist Teaching Hospital,
Nigeria
Dr Robinson Chukwudi Onoh
Chairman, Medical Advisory Committee on Viral Hemorrhagic Fever, Federal Teaching Hospital Abakaliki,
Nigeria
Dr Pierre E. Rollin
Deputy Branch Chief, Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Diseases,
Center for Disease Control and Prevention, USA
Dr David Safronetz
Chief of Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Canada
Dr Connie Schmaljohn
Senior Research Scientist, US Army Medical Research Institute of Infectious Diseases,
USA
Prof Yazdan Yazdanpanah
Director, Immunology, Inflammation and Microbiology, INSERM, France
WHO Secretariat
Dr Alejandro Costa
Initiative for Vaccine Research World Health Organization, Switzerland
Dr Janet Diaz
Team Lead - Clinical Management, World Health Emergencies programme, World Health Organization, Switzerland
Dr Pierre B. Formenty
Team Lead - Viral Haemorrhagic Fevers, World Health Emergencies programme, World Health Organization, Switzerland
Dr Pierre-Stephane Gsell
Initiative for Vaccine Research World Health Organization, Switzerland
Dr Ana Maria Henao Restrepo
Team Lead - Initiative for Vaccine Research & R&D Blueprint Coordinator World Health Organization, Switzerland
Dr Konstantin Volkmann
Consultant - Initiative for Vaccine Research World Health Organization, Switzerland
Dr Karene Yeung
Consultant - Initiative for Vaccine Research World Health Organization, Switzerland
Observers
Dr Eric D'Ortenzio
Scientific Coordinator, REACTing, INSERM, France
Dr P. Guillaume Poliquin
Senior Medical Advisor, Paediatric Infections Diseases Specialist, National Microbiology Laboratory, Canada
Prof Michael Ramharter
Head of Division of Tropical Medicine, Germany
Dr Alex Salam
Clinical, UK Public Health Rapid Support Team, UK
Dr Melanie Saville
Director, Vaccine Development, CEPI
Dr Conall Watson
Department of Infectious Disease Epidemiology London School of Hygiene and Tropical Medicine,
UK